Axitinib
Axitinib is an orally bioavailable tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.7, 1.6 nM for VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFRβ, respectively.
| Catalog Number | T1452 |
| Alternative Name(s) | AG-013736 |
| Research Area | Tyrosine Kinase/Adaptors|||Angiogenesis |
| Molecular Formula | C22H18N4OS |
| CAS# | 319460-85-0 |
| Purity | 99.27% |
| SMILES | CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Axitinib |
| Additional Information | https://www.targetmol.com/datasheet/T1452 |